ATC Group: S01GX01 Cromoglicic acid

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of S01GX01 in the ATC hierarchy

Level Code Title
1 S Sensory organs
2 S01 Ophthalmologicals
3 S01G Decongestants and antiallergics
4 S01GX Other antiallergics
5 S01GX01 Cromoglicic acid

Active ingredients in S01GX01

Active Ingredient Description
Cromoglicic acid

Sodium cromoglicate (Cromoglicic acid) inhibits the activation of many of the cell types involved in the development and progression of asthma. Thus, sodium cromoglicate inhibits the release of inflammatory mediators including cytokines from mast cells and reduces the chemotactic activity of eosinophils and neutrophils.

Related product monographs

Title Information Source Document Type  
ALLERCROM Eye drops, solution Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
NALCROM Capsule Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
OPTICROM Allergy Eye drops, solution Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
Vividrin Eye Drops 2% sodium cromoglicate Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC

Medicines in this ATC group

Austria (AT)

Canada (CA)

Cyprus (CY)

Estonia (EE)

Finland (FI)

Germany (DE)

Ireland (IE)

Israel (IL)

Lithuania (LT)

New Zealand (NZ)

Nigeria (NG)

Romania (RO)

Spain (ES)

Turkey (TR)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.